Shochiku Co., Ltd. (TYO:9601)

Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Cash & Equivalents	14,550	14,912	20,195	16,113	16,791	18,312
Cash & Short-Term Investments	14,550	14,912	20,195	16,113	16,791	18,312
Cash Growth	-16.71%	-26.16%	25.33%	-4.04%	-8.31%	-15.00%
Accounts Receivable	10,753	9,848	10,710	7,467	8,699	5,409
Other Receivables	-	738	89	-	42	820
Receivables	10,753	10,586	10,799	7,467	8,741	6,229
Inventory	11,027	9,775	6,055	5,771	5,963	6,699
Prepaid Expenses	-	1,141	1,083	1,071	1,134	867
Other Current Assets	3,519	2,535	4,010	1,350	1,767	3,203
Total Current Assets	39,849	38,949	42,142	31,772	34,396	35,310
Property, Plant & Equipment	108,018	107,937	108,001	93,036	101,304	103,377
Long-Term Investments	45,738	58,970	57,935	50,679	49,601	49,202
Other Intangible Assets	1,919	1,951	1,954	1,914	2,005	2,327
Long-Term Deferred Tax Assets	-	177	183	444	428	295
Other Long-Term Assets	17,997	1	1	2	2	2
Total Assets	213,521	208,900	211,140	178,803	188,781	191,205
Accounts Payable	8,609	6,945	8,501	6,116	7,963	5,491
Accrued Expenses	431	1,592	1,664	1,771	1,436	1,818
Short-Term Debt	6,309	7,099	4,871	4,871	4,871	4,281
Current Portion of Long-Term Debt	7,439	14,582	18,971	17,404	16,935	9,908
Current Portion of Leases	-	621	607	697	1,213	783
Current Income Taxes Payable	396	3,452	5,044	3,936	4,317	2,731
Other Current Liabilities	12,187	5,720	3,858	2,766	2,828	4,245
Total Current Liabilities	35,371	40,011	43,516	37,561	39,563	29,257
Long-Term Debt	52,979	47,152	45,335	33,887	48,791	61,266
Long-Term Leases	-	1,758	1,483	1,422	1,414	2,017
Long-Term Deferred Tax Liabilities	-	10,060	9,561	6,734	4,838	4,801
Other Long-Term Liabilities	27,306	14,798	14,687	10,739	10,782	10,654
Total Liabilities	117,580	115,749	116,675	92,322	107,949	110,599
Common Stock	33,018	33,018	33,018	33,018	33,018	33,018
Additional Paid-In Capital	30,191	30,191	30,187	30,157	30,136	30,136
Retained Earnings	16,193	15,100	16,178	13,576	8,476	10,322
Treasury Stock	-1,434	-1,430	-1,447	-1,464	-1,485	-1,470
Comprehensive Income & Other	17,881	16,176	16,431	11,103	9,889	8,176
Total Common Equity	95,849	93,055	94,367	86,390	80,034	80,182
Minority Interest	92	96	98	91	798	424
Shareholders' Equity	95,941	93,151	94,465	86,481	80,832	80,606
Total Liabilities & Equity	213,521	208,900	211,140	178,803	188,781	191,205
Total Debt	66,727	71,212	71,267	58,281	73,224	78,255
Net Cash (Debt)	-52,177	-56,300	-51,072	-42,168	-56,433	-59,943
Net Cash Per Share	-3797.17	-4097.23	-3717.57	-3070.11	-4109.00	-4364.25
Filing Date Shares Outstanding	13.74	13.74	13.74	13.74	13.73	13.74
Total Common Shares Outstanding	13.74	13.74	13.74	13.74	13.73	13.74
Working Capital	4,478	-1,062	-1,374	-5,789	-5,167	6,053
Book Value Per Share	6976.57	6771.91	6868.56	6289.11	5827.68	5837.73
Tangible Book Value	93,930	91,104	92,413	84,476	78,029	77,855
Tangible Book Value Per Share	6836.89	6629.93	6726.34	6149.77	5681.69	5668.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.